肌少症与主要不良心脑血管事件风险的关联:英国生物银行数据库研究
该研究基于英国生物银行前瞻性队列2006至2021年数据,纳入406,411名37至73岁社区居民,按EWGSOP2标准评估肌少症前期和肌少症与主要不良心脑血管事件(MACCEs)的关联。中位随访12.1年,发现肌少症前期两个亚组和肌少症均与MACCEs风险升高显著相关。
要点
- 肌少症前期(仅低握力或仅低骨骼肌指数)与MACCEs风险升高相关。
- 肌少症(低握力合并低骨骼肌指数)与MACCEs风险升高更显著。
- 社区居民中应关注肌少症前期和肌少症对心脑血管事件的预测价值。
核心结论
- 在社区居民中,肌少症前期和肌少症均与主要不良心脑血管事件风险升高显著相关。
研究设计与样本
- 基于英国生物银行前瞻性队列,纳入2006至2021年数据,共406,411名37至73岁社区居民,女性占55.7%。
- 暴露按EWGSOP2标准评估,握力评估肌力,骨骼肌指数评估肌量,定义肌少症前期两个亚组和肌少症。
- 主要结局为复合主要不良心脑血管事件(MACCEs)。
主要发现
- 中位随访12.1年(IQR 11.4至12.8),28,300名参与者(7.0%)诊断至少一次事件。
- 与无肌少症相比,肌少症前期亚组1(仅低握力)完全调整HR为1.25(95%CI 1.19至1.31)。
- 与无肌少症相比,肌少症前期亚组2(仅低骨骼肌指数)完全调整HR为1.33(95%CI 1.23至1.45)。
- 与无肌少症相比,肌少症完全调整HR为1.62(95%CI 1.34至1.95)。
关键数值与推荐
- 肌少症前期亚组1定义为低握力且骨骼肌指数正常,亚组2定义为握力正常且低骨骼肌指数。
- 肌少症定义为低握力合并低骨骼肌指数。
临床怎么用
- 在社区老年人群中,可依据EWGSOP2标准评估握力和骨骼肌指数以识别肌少症前期和肌少症。
- 对肌少症前期或肌少症个体,应关注主要不良心脑血管事件的风险升高。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Few studies on the risk of incident major adverse cardiac and cerebrovascular events (MACCEs) in sarcopenia have been reported. The objective was to assess the association between presarcopenia and sarcopenia and a higher risk of MACCEs. METHODS: This study on the UK Biobank prospective cohort, used data collected between 2006 and 2021. Community-dwelling Caucasian participants aged 37 to 73 years were included if values for Handgrip Strength (HGS) and Skeletal Muscle Index (SMI) were available and if no history of MACCEs was reported. Exposure was assessed using the European Working Group on Sarcopenia in Older People 2 (EWGSOP2) criteria. Muscle strength was measured using HGS, and muscle mass using the SMI. Presarcopenia was defined through the two definitions available in the literature, as low HGS with normal SMI and as normal HGS with low SMI, whereas sarcopenia was defined as low HGS with low SMI. The main outcome was to determine whether presarcopenia and/or sarcopenia were predictors of MACCEs (composite events). RESULTS: A total of 406,411 included participants (women: 55.7%) were included. At baseline, there were 18,257 (4.7%) presarcopenics-subgroup n°1 (low HGS only), 7940 (2.1%) presarcopenics-subgroup n°2 (low SMI only), and 1124 (0.3%) sarcopenics. Over a median follow-up of 12.1 years (IQR: [11.4; 12.8]), 28,300 participants (7.0%) were diagnosed with at least one event. Compared to NonSarc, presarcopenic (subgroups n°1 and n°2) and sarcopenic status were significantly associated with a higher risk of MACCEs (respectively fully adjusted HRs: HR = 1.25 [95% CI: 1.19; 1.31], HR = 1.33 [95% CI: 1.23; 1.45] and HR = 1.62 [95% CI: 1.34; 1.95]). CONCLUSIONS: In a community-dwelling population, the risk of MACCEs was higher in both presarcopenic and sarcopenic participants.
引用
- Jauffret C, Périchon R, Lamer A, et al. Association between sarcopenia and risk of major adverse cardiac and cerebrovascular events-UK Biobank database. J Am Geriatr Soc. 2023. PMID: 37945290. doi:10.1111/jgs.18664
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。